Skip to main content
. Author manuscript; available in PMC: 2016 Mar 4.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2013 Jul 16;22(8):e549–e556. doi: 10.1016/j.jstrokecerebrovasdis.2013.06.012

Table 3.

Etiology of ND with respect to stroke etiology

Cardioembolic
(N = 42)
Large vessel
(N = 39)
Small vessel
(N = 24)
Cryptogenic
(no cause)
(N = 2)
Cryptogenic
(>1 cause)
(N = 13)
Other (N = 8)
Patients with any ND (%)* 42/103 (40.8) 39/94 (41.5) 24/73 (32.9) 2/9 (22.2) 13/70 (18.6) 8/18 (44.4)
Reversible ND 16 15 7 1 2 4
  Infectious 7 4 2 0 2 1
  Metabolic 1 0 1 0 0 0
  Hemodynamic 5 0 4 1 0 0
  Edema 9 7 0 0 4 3
  Fluctuation 3 5 3 0 1 2
  Sedation 2 2 1 0 0 0
  Seizure 0 1 0 0 0 0
Nonreversible ND 20 19 14 1 10 3
  New stroke 1 1 0 0 0 0
  Progressive stroke 14 15 13 0 6 1
  Intracerebral hemorrhage 6 5 1 1 4 2
  Cardiopulmonary arrest 0 0 0 0 0 0
Unknown etiology 6 5 3 0 1 1

Abbreviation: ND, neurologic deterioration.

Several patients deteriorated by >1 etiology. Patients with >1 etiology of ND who experienced a nonreversible cause of ND were classified as having nonreversible ND and not categorized as having a reversible ND in the analysis comparing reversible versus nonreversible ND.

*

Percentages described are reported as the number of patients having a certain stroke etiology who experienced ND divided by the total number of patients with the respectful stroke etiology.